BRIEF-Stak Announces Pricing Of Initial Public Offering-March 2024-www.financetom.com

BRIEF-Stak Announces Pricing Of Initial Public Offering

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Stak Announces Pricing Of Initial Public Offering

Feb 25, 2025 4:05 PM

Feb 25 (Reuters) - Stak Inc:

* STAK INC. ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING

* STAK INC - PRICES IPO OF 1.25 MILLION SHARES AT $4.00 EACH

Source text:

Further company coverage:

Previous page： DHT Holdings Sells Oil Tanker for $43.4 Million Next page： Arcosa Renews $50 Million Share Buyback Program; Dividend Maintained

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

DHT Holdings Sells Oil Tanker for $43.4 Million

Dec 12, 2024

04:44 PM EST, 12/12/2024 (MT Newswires) -- DHT Holdings ( DHT ) said late Thursday it agreed to sell its very large crude carrier DHT Scandinavia for $43.4 million to an undisclosed buyer. The shipper said it expects to handover the vessel the buyer in January. DHT said it has no outstanding bank debt associated with DHT Scandinavia, adding the...

Arcosa Renews $50 Million Share Buyback Program; Dividend Maintained

Dec 12, 2024

04:44 PM EST, 12/12/2024 (MT Newswires) -- Arcosa ( ACA ) said late Thursday it renewed its $50 million share buyback plan, effective Jan. 1, 2025, through Dec. 31, 2026. The latest plan replaces the one with the same amount that will expire on Dec. 31, the company said. The company also said it kept its quarterly dividend at $0.05...

Broadcom forecasts first-quarter revenue above estimates on strong AI chip demand

Dec 12, 2024

Dec 12 (Reuters) - Broadcom ( AVGO ) forecast its first-quarter revenue above Wall Street estimates on Thursday, betting on booming demand for its custom artificial intelligence chips and networking gear from cloud providers doubling down on GenAI infrastructure adoption. Shares of the Palo Alto, California-based company rose over 3% in extended trading, having gained about 60% so far this...

Ascendis Pharma's Supplemental BLA for Adult Growth Hormone Deficiency Drug Accepted by FDA

Dec 12, 2024

04:42 PM EST, 12/12/2024 (MT Newswires) -- Ascendis Pharma ( ASND ) said its supplemental biologics license application for TransCon hGH as therapy for adult growth hormone deficiency was accepted for review by the US Food and Drug Administration. The FDA has set a July 27 review deadline, the company said Thursday in a statement. The supplemental application is based...